Lv5
1010 积分 2023-04-25 加入
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
2天前
已完结
Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions
17天前
已完结
Adebrelimab versus serplulimab plus chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: A cost-effectiveness analysis in China
18天前
已完结
Cost–Effectiveness Analysis of Serplulimab as First-Line Treatment for Advanced Esophageal Squamous Cell Carcinoma
18天前
已完结
Phase I Studies of HLX26, A Novel Anti-LAG-3 Antibody, Monotherapy or Combination Therapy in Patients with Advanced Solid Tumors
1个月前
已关闭
Adherence to medication
2个月前
已完结
Distinguishing features of a novel humanized anti-EGFR monoclonal antibody based on cetuximab with superior antitumor efficacy
2个月前
已完结
Lecanemab in Early Alzheimer’s Disease
3个月前
已完结
Incidence and prevalence of Alzheimer’s disease in China: a systematic review and meta-analysis
4个月前
已完结
Alzheimer disease
4个月前
已完结
皖公网安备34019202002308
